AstraZeneca

Latest

AstraZeneca share: The thumb stays down

AstraZeneca has been in focus in recent weeks mainly due to the COVID-19 vaccine, the approval of which is being…

Read More »
Latest

AstraZeneca: Advantage for BioNTech

BioNTech and its partner Pfizer are hoping that their corona vaccine will be approved for the market soon. Moderna is…

Read More »
Latest

In the morning: AstraZeneca, Ryanair, LVMH in focus – Nord LB column

China’s economy appears to be slow to recover from the effects of the coronavirus pandemic. Chinese producer prices fell for…

Read More »
Back to top button
Close
Close